ClinicalTrials.Veeva

Menu

Role of the Autonomic Nervous System in HIV-Lipodystrophy

H

Hannover Medical School (MHH)

Status

Completed

Conditions

Lipodystrophy-Syndrome
HIV Infections

Study type

Observational

Funder types

Other

Identifiers

NCT00149097
ANS-M26

Details and patient eligibility

About

The study aims to characterise the influence of the autonomic nervous system activity on the development of the lipodystrophy syndrome in HIV-infected patients by measuring heart rate variability and various metabolic pathways in HIV patients receiving highly active antiretroviral therapy.

Enrollment

54 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • HIV-infection
  • Age above 18 years
  • No AIDS defining event during last 6 months
  • No infection during last 6 weeks
  • No concommitant drug interfering with insulin sensitivity and ANS-activity

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems